Please assess the completion status of the following clinical trial:

Trial Title: A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients, 35-65 years of age~* Hepatic steatosis assessed by magnetic resonance spectroscopy (MRS) with liver fat \>5.56% at screening~* Body mass index (BMI) \>27 kg/m2 at screening~* Insulin resistance assessed by homeostatic model assessment-insulin resistance (HOMA-IR) \> 2.5 at screening~* Agreement to maintain prior diet and exercise habits during the full course of study~Exclusion Criteria:~* History of diabetes mellitus based on World Health Organization (WHO) criteria~* Known polycystic ovary syndrome~* Other liver disease e.g. chronic viral hepatitis, alcoholic liver disease, hemachromatosis, cirrhosis~* Known autoimmune disease or chronic inflammatory disease~* Myocardial infarction or stroke within 6 months prior to screening~* Patients taking any anti-diabetic and/or weight-lowering medication currently or within the previous 3 months before screening

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).